Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality.

Area of Science:

• Endocrinology
• Metabolic Disorders
• Clinical Research

Background:

• Hypoglycemia during hospitalization is linked to poor outcomes in diabetes patients.
• Limited research exists on the long-term effects of hypoglycemia in patients admitted for hyperglycemic crises.
• Hyperosmolar hyperglycemic crises (HHC) pose significant risks, and hypoglycemia may exacerbate them.

Purpose of the Study:

• To investigate the long-term implications of hypoglycemia in adults hospitalized for hyperosmolar hyperglycemic crises.
• To determine if hypoglycemia during HHC is associated with all-cause mortality.
• To differentiate the prognostic significance of hypoglycemia during different phases of insulin therapy.

Main Methods:

• Retrospective cohort study of 170 patients admitted for HHC (including pure HHC and hyperosmolar diabetic ketoacidosis).
• Analysis of hypoglycemia occurrence during initial intravenous insulin therapy and later subcutaneous insulin therapy phases.
• Long-term mortality assessment with a median follow-up of 652 days.

Main Results:

• Hypoglycemia was observed in 26.5% of patients during initial IV insulin therapy and 52.7% during later SC insulin therapy.
• Both hypoglycemia events were associated with increased long-term mortality.
• After adjusting for confounders, hypoglycemia during initial IV insulin therapy remained a significant predictor of mortality (HR 2.10, p=0.004).

Conclusions:

• Hypoglycemia during hyperosmolar hyperglycemic crises serves as a marker for long-term mortality.
• The occurrence of hypoglycemia during the initial intravenous insulin therapy phase is particularly indicative of increased long-term mortality risk.